Page 933 - Clinical Immunology_ Principles and Practice ( PDFDrive )

CHaPter 66 Multiple Sclerosis 901

8. Wolinsky JS, Narayana PA, O’Connor P, et al. Glatiramer acetate in 28. Gao Z, Nissen JC, Ji K, et al. The experimental autoimmune
primary progressive multiple sclerosis: results of a multinational, encephalomyelitis disease course is modulated by nicotine and other
multicenter, double-blind, placebo-controlled trial. Ann Neurol cigarette smoke components. PLoS ONE 2014;9(9):e107979. PubMed
2007;61(1):14–24. PubMed PMID: 17262850. PMID: 25250777. Pubmed Central PMCID: 4176721.
9. Hawker K, O’Connor P, Freedman MS, et al. Rituximab in patients with 29. Farez MF, Fiol MP, Gaitan MI, et al. Sodium intake is associated with
primary progressive multiple sclerosis: results of a randomized increased disease activity in multiple sclerosis. J Neurol Neurosurg
double-blind placebo-controlled multicenter trial. Ann Neurol Psychiatry 2015;86(1):26–31. PubMed PMID: 25168393.
2009;66(4):460–71. PubMed PMID: 19847908. eng. 30. Nourbakhsh B, Graves J, Casper TC, et al. Dietary salt intake and time to
10. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for relapse in paediatric multiple sclerosis. J Neurol Neurosurg Psychiatry
multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2016;87:1350–3. PubMed PMID: 27343226.
2011;69(2):292–302. PubMed PMID: 21387374. Pubmed Central PMCID: 31. Kleinewietfeld M, Manzel A, Titze J, et al. Sodium chloride drives
PMC3084507. eng. autoimmune disease by the induction of pathogenic TH17 cells. Nature
11. Willer CJ, Dyment DA, Risch NJ, et al. Twin concordance and sibling 2013;496(7446):518–22. PubMed PMID: 23467095. Pubmed Central
recurrence rates in multiple sclerosis. Proc Natl Acad Sci USA PMCID: 3746493.
2003;100(22):12877–82. PubMed PMID: 14569025. Pubmed Central 32. Voskuhl RR, Wang H, Wu TC, et al. Estriol combined with glatiramer
PMCID: 240712. acetate for women with relapsing-remitting multiple sclerosis: a
12. Hollenbach JA, Oksenberg JR. The immunogenetics of multiple sclerosis: randomised, placebo-controlled, phase 2 trial. Lancet Neurol
A comprehensive review. J Autoimmun 2015;64:13–25. PubMed PMID: 2016;15(1):35–46. PubMed PMID: 26621682.
26142251. Pubmed Central PMCID: 4687745. 33. Bove R, Musallam A, Healy BC, et al. Low testosterone is associated with
13. Baranzini SE, Mudge J, van Velkinburgh JC, et al. Genome, epigenome disability in men with multiple sclerosis. Mult Scler 2014;20(12):1584–92.
and RNA sequences of monozygotic twins discordant for multiple PubMed PMID: 24710799. Pubmed Central PMCID: 4188801.
sclerosis. Nature 2010;464(7293):1351–6. PubMed PMID: 20428171. 34. Kurth F, Luders E, Sicotte NL, et al. Neuroprotective effects of
Pubmed Central PMCID: 2862593. testosterone treatment in men with multiple sclerosis. NeuroImage Clin
14. Kurtzke JF. An epidemiologic approach to multiple sclerosis. Arch Neurol 2014;4:454–60. PubMed PMID: 24634831. Pubmed Central PMCID:
1966;14(2):213–22. PubMed PMID: 4952448. 3952353.
15. Munger KL, Levin LI, Hollis BW, et al. Serum 25-hydroxyvitamin D levels 35. Nikic I, Merkler D, Sorbara C, et al. A reversible form of axon damage in
and risk of multiple sclerosis. JAMA 2006;296(23):2832–8. PubMed experimental autoimmune encephalomyelitis and multiple sclerosis. Nat
PMID: 17179460. Med 2011;17(4):495–9. PubMed PMID: 21441916.
16. Munger KL, Aivo J, Hongell K, et al. Vitamin D Status During Pregnancy 36. Preziosa P, Rocca MA, Pagani E, et al. Structural MRI correlates of
and Risk of Multiple Sclerosis in Offspring of Women in the Finnish cognitive impairment in patients with multiple sclerosis: A Multicenter
Maternity Cohort. JAMA Neurol 2016;73(5):515–19. PubMed PMID: Study. Hum Brain Mapp 2016;37(4):1627–44. PubMed PMID: 26833969.
26953778. Pubmed Central PMCID: 4861670. 37. Carbajal KS, Mironova Y, Ulrich-Lewis JT, et al. Th Cell Diversity in
17. Levin LI, Munger KL, O’Reilly EJ, et al. Primary infection with the Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis. J
Epstein-Barr virus and risk of multiple sclerosis. Ann Neurol Immunol 2015;195(6):2552–9. PubMed PMID: 26238492. Pubmed
2010;67(6):824–30. PubMed PMID: 20517945. Pubmed Central PMCID: Central PMCID: 4561206.
3089959. 38. Moldovan IR, Rudick RA, Cotleur AC, et al. Interferon gamma responses
18. Ascherio A, Munger KL, Lennette ET, et al. Epstein-Barr virus antibodies to myelin peptides in multiple sclerosis correlate with a new clinical
and risk of multiple sclerosis: a prospective study. JAMA measure of disease progression. J Neuroimmunol 2003;141(1-2):132–40.
2001;286(24):3083–8. PubMed PMID: 11754673. PubMed PMID: 12965264. eng.
19. Lang HL, Jacobsen H, Ikemizu S, et al. A functional and structural basis 39. Hedegaard CJ, Krakauer M, Bendtzen K, et al. T helper cell type 1 (Th1),
for TCR cross-reactivity in multiple sclerosis. Nat Immunol Th2 and Th17 responses to myelin basic protein and disease activity in
2002;3(10):940–3. PubMed PMID: 12244309. multiple sclerosis. Immunology 2008;125(2):161–9. PubMed PMID:
20. Magliozzi R, Serafini B, Rosicarelli B, et al. B-cell enrichment and 18397264. Pubmed Central PMCID: PMC2561132. eng.
Epstein-Barr virus infection in inflammatory cortical lesions in secondary 40. Kebir H, Ifergan I, Alvarez JI, et al. Preferential recruitment of
progressive multiple sclerosis. J Neuropathol Exp Neurol interferon-gamma-expressing TH17 cells in multiple sclerosis. Ann
2013;72(1):29–41. PubMed PMID: 23242282. Neurol 2009;66(3):390–402. PubMed PMID: 19810097. eng.
21. Wu Z, Nagano I, Asano K, et al. Infection of non-encapsulated species of 41. Rasouli J, Ciric B, Imitola J, et al. Expression of GM-CSF in T Cells Is
Trichinella ameliorates experimental autoimmune encephalomyelitis Increased in Multiple Sclerosis and Suppressed by IFN-beta Therapy. J
involving suppression of Th17 and Th1 response. Parasitol Res Immunol 2015;194(11):5085–93. PubMed PMID: 25917097. Pubmed
2010;107(5):1173–88. PubMed PMID: 20661746. Central PMCID: 4433790.
22. Correale J. Helminth/Parasite treatment of multiple sclerosis. Curr Treat 42. Kroenke MA, Carlson TJ, Andjelkovic AV, et al. IL-12- and IL-23-
Options Neurol 2014;16(6):296. PubMed PMID: 24744099. modulated T cells induce distinct types of EAE based on histology, CNS
23. Hedstrom AK, Olsson T, Alfredsson L. High body mass index before age chemokine profile, and response to cytokine inhibition. J Exp Med
20 is associated with increased risk for multiple sclerosis in both men and 2008;205(7):1535–41. PubMed PMID: 18573909. Pubmed Central
women. Mult Scler 2012;18(9):1334–6. PubMed PMID: 22328681. PMCID: 2442630. Epub 2008/06/25. eng.
24. Langer-Gould A, Brara SM, Beaber BE, et al. Childhood obesity and risk 43. Bielekova B, Goodwin B, Richert N, et al. Encephalitogenic potential of
of pediatric multiple sclerosis and clinically isolated syndrome. Neurology the myelin basic protein peptide (amino acids 83-99) in multiple
2013;80(6):548–52. PubMed PMID: 23365063. Pubmed Central PMCID: sclerosis: results of a phase II clinical trial with an altered peptide ligand.
3589288. Nat Med 2000;6(10):1167–75. PubMed PMID: 11017150. eng.
25. Mokry LE, Ross S, Timpson NJ, et al. Obesity and Multiple Sclerosis: A 44. Polman CH, O’Connor PW, Havrdova E, et al. A randomized,
Mendelian Randomization Study. PLoS Med 2016;13(6):e1002053. placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N
PubMed PMID: 27351487. Pubmed Central PMCID: 4924848. Engl J Med 2006;354(9):899–910. PubMed PMID: 16510744. Epub
26. Poorolajal J, Bahrami M, Karami M, et al. Effect of smoking on multiple 2006/03/03. eng.
sclerosis: a meta-analysis. J Public Health (Bangkok) 2016 May 8. 45. Cohen JA, Barkhof F, Comi G, et al. Oral fingolimod or intramuscular
PubMed PMID: 27160862. interferon for relapsing multiple sclerosis. N Engl J Med
27. Ramanujam R, Hedstrom AK, Manouchehrinia A, et al. Effect of 2010;362(5):402–15. PubMed PMID: 20089954. eng.
Smoking Cessation on Multiple Sclerosis Prognosis. JAMA Neurol 46. Gold R, Giovannoni G, Selmaj K, et al. Daclizumab high-yield process in
2015;72(10):1117–23. PubMed PMID: 26348720. relapsing-remitting multiple sclerosis (SELECT): a randomised,